Concepedia

Author

Antonio Antón

Hospital Universitario Miguel Servet

Also Known As

Antonio Anton, Antonio Antón, Antonio Antón -, Antón A., Antón, Antonio, Yolanda Jerez Gilarranz

115

Publications

2.8K

Citations

19

H-Index

31

Concepts

All Affiliations

Hospital Universitario Miguel ServetHospital General Universitario Gregorio MarañónInstituto de Salud Carlos IIIComplexo Hospitalario Universitario A CoruñaGEICAM – Spanish Breast Cancer Group
AA

About

Antonio Antón is an author at Hospital Universitario Miguel Servet specializing in medicine, cancer research, and breast cancer.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

227

2

Health Sciences

2

2

84

3

Pathology

2

2

65

4

Emergency Medicine

1

1

60

5

Orthopaedics

1

1

18

Antonio Antón

×

19

Publications

2.6K

Citations

18

H-Index

YearCitations

Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group.

Michel Marty, Francesco Cognetti, D Maraninchi,

IRIS UNIMORE (University of Modena and Reggio Emilia)

2005

1.6K

Adjuvant Docetaxel for High-Risk, Node-Negative Breast Cancer

Miguel Martín, Miguel Ángel Seguí, Antonio Antón,

New England Journal of Medicine

2010

208

Obesity and survival in operable breast cancer patients treated with adjuvant anthracyclines and taxanes according to pathological subtypes: a pooled analysis

Bella Pajares, Marina Pollán, Miguel Martín,

Breast Cancer Research

2013

101

Lower Breast Cancer Risk among Women following the World Cancer Research Fund and American Institute for Cancer Research Lifestyle Recommendations: EpiGEICAM Case-Control Study

Adela Castelló, Miguel Martín, Ana Casas,

PLoS ONE

2015

100

Randomized Phase II Trial of the Efficacy and Safety of Trastuzumab Combined With Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer Administered As First-Line Treatment: The M77001 Study Group

M Marty, Francesco Cognetti, D Maraninchi,

Journal of Clinical Oncology

2005

94

A controlled trial of noninvasive ventilation for chronic obstructive pulmonary disease exacerbations

Miguel Carrera, José M. Marı́n, Antonio Antón,

Journal of Critical Care

2009

60

Fluorouracil, Doxorubicin, and Cyclophosphamide (FAC) Versus FAC Followed by Weekly Paclitaxel As Adjuvant Therapy for High-Risk, Node-Negative Breast Cancer: Results From the GEICAM/2003-02 Study

Miguel Martín, Manuel Ruíz Borrego, Agustí Barnadas,

Journal of Clinical Oncology

2013

56

Physical activity and breast cancer risk by pathological subtype

Virginia Lope, Miguel Martín, Adela Castelló,

Gynecologic Oncology

2017

45

Practical prognostic index for patients with metastatic recurrent breast cancer: retrospective analysis of 2,322 patients from the GEICAM Spanish El Alamo Register

Javier Puente, Sara López‐Tarruella, Aňa Lluch,

Breast Cancer Research and Treatment

2010

43

Discontinuing noninvasive ventilation in severe chronic obstructive pulmonary disease exacerbations: a randomised controlled trial

Jacobo Sellarés, Miquel Ferrer, Antonio Antón,

European Respiratory Journal

2017

40

Page 1